GO
Loading...

Regulations

More

  • BEIJING, July 24- China's antitrust regulator has confirmed that Qualcomm Inc, one of the world's biggest mobile chipmakers, has a monopoly, the state-run Securities Times newspaper reported on Thursday, as Qualcomm's chief executive held talks in China.

  • SHANGHAI, July 24- China's food regulator has visited close to 600 restaurants, businesses and food distributors as it investigates a fast-spreading food safety scare that has dragged in a number of global brands and hit food outlets as far away as Japan.

  • SHANGHAI, July 24- China's food regulator has visited close to 600 restaurants, businesses and food distributors, the watchdog said in a statement, in an investigation into a fast-spreading food safety scare. The safety scare has already dragged in U.S. chains McDonald's Corp, KFC-parent Yum Brands Inc and coffee giant Starbucks Corp..

  • Standard & Poor's may face SEC charges over ratings Wednesday, 23 Jul 2014 | 6:52 PM ET

    In a regulatory filing, McGraw-Hill Financial Inc said it received a "Wells notice" on July 22 indicating the SEC is weighing filing civil charges for alleged securities law violations over S&P's ratings of six commercial mortgage-backed securities transactions issued in 2011..

  • WASHINGTON, July 23- The U.S. ethanol industry pushed back on Wednesday against what they called a "one size fits all" approach to proposed federal rules for shipping fuel by rail, saying regulators must distinguish between the often corn-based biofuel and crude oil.

  • SEC considering action against S&P over ratings Wednesday, 23 Jul 2014 | 5:56 PM ET

    S&P's parent McGraw Hill Financial Inc. disclosed in a regulatory filing that it has received a so-called "Wells Notice" from staff of the Securities and Exchange Commission. S&P has been cooperating with the SEC in the matter and will continue to do so, New York- based McGraw Hill said. SEC spokeswoman Gina Talamona declined to comment.

  • AT&T CEO SAYS BRAZIL'S ANTITRUST REGULATOR APPROVED WITHOUT RESTRICTIONS DIRECTV MERGER.

  • FCC Chairman Tom Wheeler has sought to establish himself as a strong defender of consumer interests who would punish ISPs whose business practices may hurt consumers or competition.

  • July 23- The U.S. Securities and Exchange Commission has approved a new brokerage industry rule to ban dispute settlements between securities firms and investors that require investors to agree to erase complaints from brokers' public records.

  • WASHINGTON, July 23- U.S. regulators and 15 states announced a wave of lawsuits on Wednesday against law firms and mortgage assistance companies they said have scammed borrowers since at least 2011 by falsely promising home loan modifications and other foreclosure relief.

  • July 23- The U.S. Food and Drug Administration said on Wednesday it has approved Gilead Sciences Inc's Zydelig, a drug to treat three types of blood cancer. The FDA approved the use of Zydelig in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.

  • July 23- The U.S. Securities and Exchange Commission has approved a new brokerage industry rule to ban dispute settlements between securities firms and investors that require investors to agree to erase complaints from brokers' public records.

  • SAN FRANCISCO/ FRANKFURT, July 22- European Union antitrust regulators are preparing to step up investigations of Google Inc's practices on several fronts and are likely to revise certain terms of a settlement involving its search engine that was proposed earlier this year, the Wall Street Journal reported on Tuesday.

  • German city Hamburg seeks to ban Uber ride service Wednesday, 23 Jul 2014 | 12:59 PM ET

    HAMBURG/ FRANKFURT, July 23- Hamburg has told Uber, a U.S. car service whose smartphone app summons rides at the touch of a button, to stop operating in the German city, adding to resistance the company has faced globally from local regulators and taxi drivers.

  • FDA approves Gilead Sciences drug for 3 cancers Wednesday, 23 Jul 2014 | 12:57 PM ET

    WASHINGTON— The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. The FDA has approved three other drugs for the disease in the last year: Roche's Gazyva, Janssen Pharmaceutical's Imbruvica and GlaxoSmithKline's Arzerra.

  • U.S. FDA approves Gilead's blood cancer drug Zydelig Wednesday, 23 Jul 2014 | 12:05 PM ET

    July 23- The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday. The FDA approved it for use in combination with Roche AG's Rituxan for patients with relapsed chronic lymphocytic leukemia.

  • SEC adopts money market reforms in 3-2 vote Wednesday, 23 Jul 2014 | 12:02 PM ET

    The SEC adopted rules designed to curb the risk of investor runs on money market funds.

  • Protections set up by the U.S. Food and Drug Administration called "risk evaluation and mitigation strategies", which can curb distribution of dangerous medicines, have been used to prevent generic drugmakers from getting the drugs in order to test their own versions, which is required to win FDA approval, the report from the Generic Pharmaceutical Association said.

  • WASHINGTON/ HONG KONG, July 23- A member of the U.S. Commodity Futures Trading Commission will become the new head of a bank lobby group that is fighting the derivatives regulator in court over a crucial new rule curtailing Wall Street.

  • July 23- Eagle Pharmaceuticals Inc said the U.S. Food and Drug Administration approved its drug to treat an inherited life-threatening condition called malignant hyperthermia. Eagle Pharmaceuticals is also testing Ryanodex for use in exertional heatstroke.